Medical News on Cancer
Protein That Binds To Growth Factor Receptor, Priming It For Normal Function, Likely Linked To 4 Cancers
Jun 26, 2012
Once considered merely a passive link between proteins that matter, Grb2 - pronounced "grab2" - actually lives up to its nickname with its controlling grip on an important cell signaling pathway, scientists at The University of Texas MD Anderson Cancer Center report in Cell... Read More
New Treatment Associated With Improved Cognition In Cancer, Alzheimer's Patients
Jun 26, 2012
Growth factors shown to cure Alzheimer's disease in a mouse model and administered to cancer patients as part of their treatment regimen were linked to significant improvements in the patients' cognitive function following stem cell transplantation, a preliminary clinical study reports... Read More
Augmenting Blood System Protein Pathway Protects Against Radiation Poisoning
Jun 26, 2012
New research in Nature Medicine shows that boosting a protein pathway in the body's blood making system protects mice from otherwise fatal radiation poisoning... Read More
Pluristem Therapeutics' Cell Therapy Broadens Addressable Markets - Demonstrates Systemic Effectiveness Of Intramuscular Delivery
Jun 26, 2012
Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE: PLTR) announced last week at the 2012 Bio International Convention the results of a pre clinical study it conducted measuring the effectiveness of its Placental eXpanded (PLX) cells when administered intramuscularly(IM). Cell therapies are traditionally delivered through intravenous (IV) injections for systemic effect... Read More
Dabrafenib Shows Promise For Melanoma Patients
Jun 25, 2012
Results of the 'BREAK3 trial, a Phase III study of dabrafenib to treat patients with BRAF mutation-positive melanoma, i.e. a type of advanced skin cancer that works by inhibiting a key signaling protein, has demonstrated that these patients have better results with dabrafenib than with chemotherapy. The study has been published Online First in The Lancet... Read More
Cancers With Disorganized 'Traffic Systems' More Difficult To Treat
Jun 25, 2012
Medical researchers at the University of Alberta reviewed test results from thousands of patients with various types of cancer and discovered that "disorganized" cancers were more difficult to treat and consistently resulted in lower survival rates... Read More
Stopping And Starting Cancer Cell Cycle Weakens And Defeats Multiple Myeloma
Jun 25, 2012
Weill Cornell Medical College researchers have devised an innovative boxer-like strategy, based on the serial use of two anti-cancer drugs, to deliver a one-two punch to first weaken the defenses of multiple myeloma and then deliver the final knock-out punch to win the fight... Read More
New Lung Cancer Screening Guidelines
Jun 25, 2012
A lung screening and surveillance task force, established by the American Association for Thoracic Surgery (AATS) and led by medical professionals from Brigham and Women's Hospital (BWH), is strongly recommending new guidelines for lung cancer screening. The guidelines were published in the online edition of the Journal of Thoracic and Cardiovascular Surgery (JTCVS)... Read More
Myelodysplastic Syndrome Patients Treated With Deferasirox Show Beneficial Iron Reduction
Jun 25, 2012
Researchers at Moffitt Cancer Center and colleagues at six other institutions have recently tested a treatment for patients with myelodysplastic syndrome, or MDS, a blood-related malignancy that involves the ineffective production of blood cells, leaving patients anemic and in need of frequent blood transfusions... Read More
Examining The Biology Of Tumor-Derived Microvesicles
Jun 25, 2012
A new paper by Crislyn D'Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients... Read More
Previous Page Next Page